- China FDA Announces Implementation Scheme to Improve the Drug Approval System (November 19, 2015)
- Chinese Legislature Adopts Amendments to Drug Administration Law (April 30, 2015)
- China Announces Final Biosimilars Guideline (March 6, 2015)
- China Announces Revised Good Clinical Practices for Public Comments (February 13, 2015)
- China Expects Major Changes in Drug Registration and Contract Manufacturing Rules (November 18, 2013)
- China Releases Vaccine Good Clinical Practices (November 9, 2013)
- China Solicits Comments on Post-Market Study Guidelines (October 29, 2013)
- China Solicits Comments on New Drug Technical Review Guidelines (October 12, 2013)